1. General information. Editorial Policy
2. Preparation and submission of manuscripts
3. Process for review of manuscripts
4. Guarantees and responsibility of the author
5. Ethics in publishing
6. Conflict of interest
1) General information. Editorial Policy
The Journal of Osteoporosis and Mineral Metabolism (abbreviated as ROMM, from the Spanish title La Revista de Osteoporosis y Metabolismo Mineral, Rev Osteoporos Metab Miner; www.revistadeosteoporosisymetabolismomineral.es) is the official scientific journal of the Spanish Society of Bone and Mineral Metabolism Research (Sociedad Española de Investigación Ósea y del Metabolismo Mineral, SEIOMM), which maintains all rights thereof. The journal publishes every three months (4 issues per year, spring, summer, autumn and winter), with a variable number of extra specialized editions. The autumn issue is intended for the publication of communications from the annual SEIOMM Congress.
The ROMM publishes papers in Spanish, which are translated into English, and is available free of charge through its website.
The management and editing of the ROMM is carried out by 2 committees and a publishing firm:
- The Steering Committee, formed by the Director (who officially and legally represents the publication, directs ROMM activities and carries out or proposes actions for its improvement) and the Editor (responsible for the registration and the process of revision of submitted manuscripts). This committee decides which manuscripts will be published and the content of each issue.
- The Editorial Committee, formed by the President of SEIOMM and a group of researchers and experts of international prominence, consults and advises the Steering Committee.
- The Editorial BOARD: responsible for the reception of manuscripts, their layout and publication in the ROMM, as well as the maintenance and updating of the Journal Web page, all supervised by the Steering Committee with a publishing company hired ad hoc by SEIOMM.
Originality or non-publication policy
The manuscripts submitted to ROMM must not have been published previously. The so-called Ingelfinger Rule is the policy applied, for two reasons. First, to allow time for independent review of scientific results prior to public dissemination, and furthermore, to ensure content originality. The rule also calls for researchers not to provide the details of their findings to the media before their work can be peer reviewed and published.
Open access policy online
The ROMM does not have an embargo, a grace period or precise registration for accessing its contents. Each article can be read immediately, such as “Advance of upcoming issues”, or in its corresponding issue once it is definitively published. All articles may be read or downloaded free of charge, in both Spanish and English. The magazine does not charge authors for sending or publishing their articles in any of its forms. Thus, it is completely free.
Self-archiving policy and reuse of published articles
Authors or authorized third parties are allowed to deposit, in institutional repositories, theme-based repositories or on personal pages, the files corresponding to the articles published in the Journal of Osteoporosis and Mineral Metabolism.
Peer review policy
Each manuscript will be reviewed by two highly competent, renowned individuals in the relevant area of the submitted manuscript. Authorship of the manuscript is withheld to avoid subjectivity concerns. Therefore, the review will be double-blind: neither the two reviewers will know the identity of the authors nor will the authors know the reviewers’ identity. The ROMM guarantees the strict compliance of double anonymity in this process.
Of the manuscripts published as “advance of next issues” the Steering Committee will decide which and at which time they will be published in the different issues of the ROMM, according to editorial requirements. The ROMM is responsible for the translation into English of all manuscripts.
In general, the review and publication process will be completed in 3 months, depending, of course, on compliance with the deadlines set at any time by both reviewers and authors.
Directorate role and drafting of the ROMM in the review and approval of published material:
The Steering Committee directs and supervises ROMM policies and is responsible for maintaining its scientific and literary quality. Their first obligation is to ensure that all authors receive confidential, expert, critical and impartial comments on their paper.
The Steering Committee, the Editorial Committee and the Publishers will not disclose any information about a manuscript sent for review to anyone, except the reviewers in order to properly carry out their work, the authors themselves or those working on their behalf.
The Management Committee and the Editorial Committee may not participate in the editorial management of reports in which they have any conflicts of interest.
The Steering Committee, the Editorial Committee and the Editorial cannot use unpublished information of the type that is of a manuscript sent without the written permission of the author.
The judgments and opinions expressed in the articles published in the Journal of Osteoporosis and Mineral Metabolism are those of the author or authors, and not necessarily of their Committees. Both ROMM and SEIOMM decline any liability in this respect. Neither the ROMM, represented by its Committees, nor the SEIOMM guarantee or support any product that is announced in the ROMM, nor guarantee the affirmations made by the manufacturer on said product or service.
All ads are subject to the approval of the ROMM, which reserves the right to refuse or cancel any advertisement at any time. Since the ROMM is an exclusively digital magazine, advertising will be displayed on its website, not inside each issue. Advertising shall be controlled by the Board of Directors of SEIOMM, which shall take into account the Management Committee’s opinion. Neither the Director nor the Publisher will be responsible for any possible error in publishing any accepted advertisements.
All ads must clearly identify the advertiser by brand or firm.
Conflict of interest policy, human and animal rights and informed consent for publications
The Editorial Committee reserves the right to reject manuscripts that do not meet acceptable standards of research behavior as determined by the Belmont report, the Helsinki Declaration and the Geneva Convention.
Human research subjects
All studies performed with human subjects or human tissues must be in accordance with the principles set out in the Helsinki Declaration for publication and must have been formally approved by an Ethics Committee, Clinical Trials or equivalent. All manuscripts must indicate expressly that such approval was obtained. In text and data in tables and figures subjects should be identified by numbers or letters instead of their names or initials. Photographs of patient faces may be included only if it is scientifically relevant. Authors must obtain written authorization from the patient for the use of such photographs, which must also be expressly indicated in the manuscript.
Guidelines for the Care and Use of Experimental Animals
ROMM requires that studies involving the use of animals be conducted under standardized animal protection standards. The adequacy of the experimental procedures, as well as the species and number of animals used, should be considered in the design of any study. All research animals must be acquired and used in accordance with international, national and institutional regulations. In particular, ROMM recommends keeping animals in accordance with the following international and national guidelines for the care and use of laboratory animals:
– “Guide to the Care and Use of Laboratory Animals,” published by the National Research Council and sponsored by the National Institute of Health, NIH) in Washington, USA (the latest edition – 7th was published by National Academy Press, USA, 1996): https://www.nap.edu/read/5140
– Council Directive 86/609 / EEC of 24 November 1986 on the approximation of the laws, regulations and administrative provisions of the Member States of the European Economic Community concerning the protection of animals used for experimental purposes and other scientific purposes. Published in the Official Journal of the European Communities. No L 358/1 of 18 December 1886.
– Transparency agreement on the use of animals in scientific experimentation in Spain. From the Confederation of Scientific Societies of Spain (COSCE).
Research animals should receive adequate tranquilizers, analgesics, anesthetics and care to minimize pain and discomfort during preoperative, operative and postoperative procedures. Animal health must be properly supervised. If the study or condition of the animals requires that they be sacrificed, it will be done compassionately.
Policy on the process for handling cases that require corrections, retractions and editorial reports
The ROMM notes scientific misconduct, expressions of interest and retraction as outlined in the recommendations of the International Committee of Medical Journal Editors (ICMJE):
It is the responsibility of each person who appears as the author of an article published in the ROMM who has contributed in a significant and identifiable way to the design, execution, analysis and writing of the article, and must agree with all aspects of the work.
The author who refers the article to the journal must include a note in the cover letter stating that all the signatories have actively collaborated in the preparation of the manuscript in its different phases. For more information on these sections (please see: http://www.icmje.org/2).
2) Preparation and submission of manuscripts
All manuscripts should be prepared in accordance with the International Committee of Medical Journal Editors recommendations, available at: http://www.icmje.org/
They will be emailed to the address email@example.com.
The submitted manuscripts must correspond to one of the following sections:
Any clinical or experimental research work of any type, which must be related to bone mineral metabolism, shall be considered original.
2. Clinical Notes
Description of one or more clinical cases of exceptional observation that suppose an important contribution to the knowledge of bone mineral metabolism.
3. Short Originals
Clinical or experimental work which, due to its special characteristics (reduced number of observations, research work with a specific objective and results, descriptive epidemiological studies, etc.) cannot be published as original documents, but in Abbreviated form.
4. Osteology Images
In this section, images (radiological, anatomopathological, clinical, etc.) will be admitted, up to a maximum of 4, related to the osteology and mineral metabolism field. They must be accompanied by explanatory text.
5. Letters to the Editor
In this section, letters will be published that refer to works published in the ROMM previously and those that contribute opinions, observations or experiences that by their characteristics can be summarized in a brief text.
6. Other Sections
The ROMM includes other sections (Editorials, Revisions and Documents or Special Articles), which will be commissioned by the Director. Authors wishing to collaborate in any of these sections should first consult the Director of the ROMM.
They will preferably be requested by the Director, although they may also be sent on the initiative of the authors, who must previously have the V º Bº of the Director, and in which case they will undergo a revision process.
They will be requested by the Director.
6.3. Special Documents
This section encompasses all those documents and articles that could make any scientific contribution to the field of bone mineral metabolism and that possess characteristics that do not allow their inclusion in any of the previous sections of the ROMM. The Editorial Committee will decide how to publish these documents, and reserves the right to modify them to fit the journal’s format.
All manuscripts must be accompanied by a cover letter stating: 1) the section of the ROMM in which it is wishes to be published; 2) a brief explanation of the original contribution and relevance of the work in the field of bone metabolic pathology; 3) the statement that the manuscript is original and has not been submitted simultaneously for evaluation in any other journal; and 4) that all instructions given by the ROMM have been observed, including those related to authorship.
ELABORATION OF THE MANUSCRIPTS
The manuscript must be written in Spanish. The full text of the manuscript, from the title page to the references, must be included in a file written in Word, with Arial font size 12, spaced 1.5 lines and justified to the left. The pages will be numbered correlatively in the upper right margin and a margin of 3 cm should be left on the 4 edges of the page (which will be A4 size).
Only common abbreviations should be used in the field of Medicine and avoid the use of abbreviations in the title and abstract of the work. The first time an abbreviation appears must be preceded by the full term to which it refers, except in the case of units of common measures, which shall be expressed according to the International System.
The papers should include the following information, ordered as follows: title page and authors, abstract page and keywords, main text (introduction, material and method, results, discussion and bibliography), tables and figures. If necessary, tables and figures may be included in another attachment, including in PowerPoint format if desired, with their respective titles and numbering.
1. Sections of the manuscripts
1.1. TITLE PAGE AND AUTHORS:
This will contain the following information:
– The title, which should properly describe the content of the paper. It should be brief, clear and informative. It should include the complete names of the authors, with separate surnames or hyphenated where necessary as preferred. There will be a limited number of authors per manuscript, depending on the type in question, with 10 authors maximum for original articles, six for clinical notes and three for brief originals, images in osteology, letters to the editor and reviews. In the case of special documents, the maximum number of the authors will be in accordance with the journal’s editorial board.
– The full name and surnames of the authors must be included, separated or linked by script, depending on how authors prefer to appear in the publications.
– The name of the department (s) or service (s) and the institution (s) to which the authors belong. The academic or professional position of the authors should not be included.
The full name, e-mail address (if available) and the full postal address of the author to whom the correspondence is addressed will also be included, which will be responsible for correcting the evidence.
There will be recognition of any grant or financial assistance, as well as the declaration of the existence or otherwise of conflicts of interest of each of the authors and of observing the precepts of the Helsinki declaration on clinical studies; and, if applicable, the declaration of having observed the regulations for the care and use of experimental animals.
1.2. SUMMARY AND KEYWORDS
The structured abstract should appear on the second page of the manuscript and its maximum length will be 250 words in the case of originals and revisions, and 150 in clinical notes and short originals. The rest of the manuscripts will not require summary.
It will have the following headings: Objectives, indicating the fundamental purpose of the work; Materials and Methods, explaining the design of the study, the criteria for the evaluation of the diagnostic tests and the temporal direction (retrospective or prospective). The procedure for selecting patients, the inclusion and/or exclusion criteria, and the number of patients begin and end the study. If it is an experimental work, indicate the number and type of animals used; Results, which will record the most relevant and significant results of the study, as well as its statistical evaluation; Conclusions, which will mention those that are supported directly in the data, along with its clinical applicability. The same emphasis should be given to positive and negative findings with similar scientific interest.
The key words from 3 to 10 in total will be included in the abstract, with the aim of complementing the information contained in the title and helping to identify the work in the bibliographic databases. For keywords, terms equivalent to those obtained from the list of descriptors in Health Sciences of the Medical Subject Headings (MeSH) of the US National Library of Medicine (NLM), available at:
Important: It is not necessary to send the abstract or keywords in English. This will be done by the ROMM translator.
1.3. TEXT OR BODY OF THE MANUSCRIPT.
They will have a maximum extension of 16 pages and will allow up to 5 tables or figures. They should be structured as follows:
The objectives of the work should be clearly mentioned and the basis of the work should be summarized without extensively revising the theme and eliminating historical memories. Cite only those references that are strictly necessary.
1.3.2. Materials and methods
In this section the place, time and population of the study must be specified. Authors should include information on how the design was done, how the subjects were selected; for all techniques, what analytical determinations and other tests or measurements were carried out. All this in should be sufficiently detailed so that other researchers can reproduce the study without difficulties.
At the end of this section, indicate the type of statistical analysis used, specifying the confidence interval. The studies will have the corresponding experiments or control groups; Otherwise, the measures used to avoid bias will be explained and its possible effect on the study’s conclusions will be discussed. If it is an original methodology, the reasons that have led to its use will be explained and its possible limitations will be described.
Patient names should not be shown or any information included that may lead to their identification. With respect to drugs, the generic name of the drugs used in the study will be published, avoiding their trade names, and detailing the maximum dose prescribed, the route of administration and the time of administration.
It will also indicate the ethical standards followed by researchers in both human and animal studies. Studies in humans should have the express approval of the local Ethics and Clinical Trials Committee. The authors should mention that the procedures used in patients and controls have been performed after obtaining informed consent.
The results must be presented in a logical and concordant sequence in the text and tables and figures. Data can be displayed in tables or figures, but not simultaneously in both tables. The text should highlight the important observations, without repeating all the data presented in the tables or figures. The presentation of the results should not be mixed with their discussion.
It is a discussion of the results obtained in this work and not a review of the subject in general. The authors should highlight the new and important aspects that their work contributes and the conclusions that are proposed from them. Do not repeat in detail data that appear in the results section. In the discussion, the authors should influence the concordances or disagreements of their findings and their limitations, comparing them with other relevant studies, identified through the respective bibliographical references. In the end, the conclusions obtained should be related to the objective (s) of the study, as described in the introduction. Authors should avoid formulating conclusions that are not supported by the findings, as well as to support these conclusions in other works not yet completed. If necessary, authors may come up with new hypotheses, but these should be clearly identified as such. Where appropriate, authors may propose recommendations.
They should not exceed 40 bibliographic citations. Only those citations that are considered important and have been read by the authors will be included. All references must be cited in the text consecutively according to the order of appearance, and identified by https://www.nlm.nih.gov/bsd/uniform_requirements.html
They shall be numbered with Arabic numerals in the same order of appearance in the text, and shall be included in the manuscript, at the end of the same, after the bibliography. They will be prepared to space and a half, like the rest of the manuscript, and the typeface should not be changed. They will be identified with the corresponding numbering and a brief but sufficiently explanatory title in its upper part. The legend of the table must allow to understand its content, without the reader having to go to the text for his understanding. Each column in the table must contain a short header. The necessary explanatory notes should be included in the table and use lowercase letters in superscript and in alphabetical order (a, b, c) or symbols such as asterisk (*), pad (#), and others, also in superscript, as long as they are well distinguishable from each other.
The statistical measures of variation, such as the standard deviation and the standard error of the mean, should be included in the tables. Only decimals with clinical significance will be used; For example, the blood glucose of 89.67 should be expressed as 89.7.
All graphics, photographs and drawings are considered figures. The figures will be identified with Arabic numerals that match their order of appearance in the text. The feet of the figures will be prepared to space and a half in separate pages. The legends and the feet of the figures must contain enough information to be able to interpret the presented data without having to resort to the text. For the explanatory notes at the foot of figure, calls in the form of lower case letters or superscripted symbols will be used, as indicated above in the tables. Photographs of histological preparations should include the type of staining and the increase. The minimum resolution of the images should be 300 dpi (dots per inch).
In addition to the abstract, a short introduction (150 words maximum) must be attached, both of which precede the description of the case. The maximum length of the text is 5 pages (1,750 words, 10,650 characters with spaces). Up to two figures and two tables will be supported. It is advisable that the number of signers does not exceed six and that not more than 20 references are included.
These works must have a maximum extension of 5 pages of text, not exceeding 10 bibliographical references and without contributing more than 3 illustrations (figures, tables or images). The maximum number of signatories must not exceed six. Its structure will be like that of the original articles.
IMAGES OF OSTEOLOGY
They must be accompanied by an explanatory text whose maximum length will be 2 pages.
LETTERS TO THE EDITOR
In this section, letters will be published that refer to works previously published in the ROMM and those that contribute opinions, observations or experiences that by their characteristics can be summarized in a brief text. The maximum extension will be 60 lines and a figure or a table and ten bibliographical references will be accepted as maximum. The number of signatories should not exceed four.
They will be presented with a maximum extension of 12 pages (4,200 words, 25,560 characters with spaces) and a maximum of 60 citations. There will be a maximum of 4 figures and 5 tables that should contribute in an evident way to the best understanding of the text. They will have a final section of conclusions of approximately one extension sheet.
T hey will have a maximum length of 4 pages (2,100 words, 12,780 characters with spaces), without tables or figures, and a maximum of 30 bibliographic citations.
3. Process for review of manuscripts
Upon receipt of a new manuscript in the Editorial, the editors will acknowledge by e-mail as soon as possible, and forward it to the Editor, who will register the manuscript, assigning a reference number, and notify the author responsible for the manuscript. The correspondence said record, as well as the beginning of the review process. It will also be the person responsible for managing the anonymous peer review process, and will ensure that it is completed within a maximum period of 3 months, as far as possible.
Prior to the beginning of the review process, the first evaluation of the authors’ compliance with the publication rules will be carried out from the Writing Office. In case of significant non-compliance, the manuscript will be returned to the authors before beginning the review process, asking them to rectify the errors detected.
In case the manuscript is suitable for revision, or once the errors indicated in the previous paragraph have been corrected, the Editor will contact the potential reviewers that the Management Committee has selected. It is acceptable for authors to suggest names of persons whom they believe are appropriate and qualified to perform a fair and impartial review of their manuscript, which, in addition to their first name and surname, should include their e-mail and the reasons for which they consider they can evaluate Objectively the article. They may also indicate those reviewers who do not wish to evaluate the manuscript, and must also justify this data, although its management will be absolutely confidential by the management team of the ROMM. Once potential reviewers have agreed to read and comment on a manuscript, they are given a period of about 3 weeks to complete the report.
Upon receipt of and based on the reports, the Steering Committee will make a decision, either: accept; Give authors the opportunity to review and make corrections; Or reject the manuscript. In case there is no clear decision to obtain contradictory reports, the Editor will forward the manuscript to the Editorial Board, who will finally decide. The decision letter and comments will be sent to the corresponding author from the Editor.
Revised and corrected manuscripts are again evaluated by the same reviewers to determine if the authors have observed and performed satisfactorily the suggestions and considerations of the reviewers and the Editorial Committee in their case. Depending on this evaluation, the manuscript may be definitively accepted or rejected. If the work is accepted, a final style review will be made by the Editor, who will forward it to the editors for their layout. Prior to its online publication, the Vº Bº of the gallery will be requested from the authors in order to correct possible errata, after which it will be immediately available on the ROMM website.
All correspondence between the Editor with the reviewers and the corresponding author, carried out during the review process, will be carried out exclusively by electronic mail.
Reviewers should follow the guidelines of the COPE ethical guidelines for peer reviewers http://publicationethics.org/files/Peer%20review%20guidelines_0.pdf
Obligations of reviewers
The critical and confidential review of manuscripts is an essential element of research publications. Every scientist has the obligation to contribute to the peer review process as a reviewer. The reviewers will not receive any remuneration for their work. Among the duties of the reviewers is to be an expert on that subject, to be critical and committed to a constructive scientific and literary assessment of the research according to their knowledge, skills and experience, all in a fair and impartial manner. In order to facilitate the rapid exchange of scientific results, it is also the duty of each reviewer to respond diligently to requests for review and complete their tasks promptly and within the timeframe suggested by the Editor. If there is a delay in its review, the reviewer has the obligation to notify the Editor, who may replace it with another reviewer if the delay is such as to prejudice the review process. Those who are members of the Committee of Experts of the ROMM and do not fulfill their obligations or repeatedly reject requests for review will be removed from the same.
Reviewers should not review a manuscript if: 1) they do not believe that they are competent to evaluate the research described, 2) they guess, despite the anonymity, the authorship of the manuscript and believe that there is a conflict of interest or personal or professional relationship with the manuscript. Author (s) could bias the evaluation of the manuscript, or (3) there is any other situation that could bias their review.
Working in the same institution as one of the authors does not automatically represent a conflict. In those circumstances in which the reviewers cannot, must or wish to carry out a review, they must notify the Editor as soon as possible, so as not to delay the review process.
The reviewer should strive to make accurate, detailed and constructive criticisms, and reviews should have appropriate references, especially if unfavorable. The reviewer should also bear in mind if the work of others is correctly quoted. If, at the time of the review, the reviewer notes any substantial resemblance of the manuscript to a published article or a manuscript sent simultaneously to another journal, they must immediately inform the Editor.
No part of the manuscript under review ordinarily should be disclosed to another person without the permission of the Editor. If a reviewer consults with a colleague at a specific time, this fact and the name of the collaborator or consultant should be notified to the Editor, preferably in advance.
Since the correspondence with the reviewers is exclusively by electronic mail, the reviewers undertake to report changes in their electronic address to the ROMM Editor (firstname.lastname@example.org).
The list of collaborators that form the Committee of Experts is published on the ROMM website. Also, in the last issue of each year the names of the reviewers who have collaborated specifically in this year are published.
4. Guarantees and responsibility of the author
When sending e-mail work, the author ensures that all material submitted to the Journal of Osteoporosis and Mineral Metabolism for publication is original, and that it has not been previously published or simultaneously submitted to any other Journal for publication.
The author also warrants that the work complies refers Data Protection Act and has obtained the prior written consent of patients or their relatives for publication.
5. Ethics in publishing
Potential conflicts of interest for all authors should be discussed in a separate document. An electronic cover letter from the corresponding author is acceptable. Authors of research articles should disclose any affiliation with any organization with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (eg, consultancies, employment, expert testimony, honoraria, retainers, stock) that may affect the conduct or reporting of the work submitted. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure. Because reviews and editorials are based on selection and interpretation of the literature, the Journal expects that authors of such articles will not have any financial interest in a company (or its competitor) that makes a product discussed in the article. Information about potential conflict of interest will be made available to reviewers and will be published with the manuscript at the discretion of the editors.
6. Conflict of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If there are no conflicts of interest then please state this: ‘Conflicts of interest: none’.